Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs9939609
rs9939609
FTO
0.800 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs13266634
rs13266634
0.100 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs1805192
rs1805192
0.100 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs5219
rs5219
0.100 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs9926289
rs9926289
FTO
0.010 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs1333049
rs1333049
0.740 GeneticVariation BEFREE Genotype CC of rs1333049 was significantly associated with both elevated CRP levels and decreased HDL concentrations after univariate (p = 0.028, p = 0.012) and multivariate analysis (p = 0.041, p = 0.023) stratified for age, gender, body mass index, smoking, diabetes, and severe periodontitis. 31770616

2020

dbSNP: rs7903146
rs7903146
0.100 GeneticVariation BEFREE There is a trend toward an association between faster GE and the diabetes-associated allele at rs7903146 in TCF7L2. 31691451

2020

dbSNP: rs550057
rs550057
ABO
0.010 GeneticVariation BEFREE Genetically instrumented blood lead was not associated with CAD (odds ratio (OR) 1.01 per effect size of log transformed blood lead, 95% confidence interval (CI) 0.97, 1.05), blood pressure (systolic -0.18 mmHg, 95% CI -0.44 to 0.08 and diastolic -0.03 mmHg, 95% CI -0.09 to 0.15) or diabetes (OR 0.98, 95% CI 0.92 to 1.03) using MR-PRESSO estimates corrected for an outlier SNP (rs550057) from the highly pleiotropic gene ABO. 31690775

2019

dbSNP: rs201264306
rs201264306
0.020 GeneticVariation BEFREE One novel mutation (p.I99_C100insSI) and three previously reported variants (p.G32S, p.R89C and p.C96R) in INS were identified in four infants with early-onset diabetes. 31605659

2019

dbSNP: rs372098146
rs372098146
0.010 GeneticVariation BEFREE Here we expressed, in dPdxk<sup>1</sup> mutant flies, four PDXK human variants: three (D87H, V128I and H246Q) listed in databases, and one (A243G) found in a genetic screening in patients with diabetes. 31578392

2019

dbSNP: rs377592729
rs377592729
0.010 GeneticVariation BEFREE Here we expressed, in dPdxk<sup>1</sup> mutant flies, four PDXK human variants: three (D87H, V128I and H246Q) listed in databases, and one (A243G) found in a genetic screening in patients with diabetes. 31578392

2019

dbSNP: rs2910164
rs2910164
0.030 GeneticVariation BEFREE In conclusion, this meta-analysis indicated that miRNA27a rs895819 might play a protective role in diabetes, and miRNA146a rs2910164 likely had no association with diabetes. 31577754

2019

dbSNP: rs895819
rs895819
0.020 GeneticVariation BEFREE In conclusion, this meta-analysis indicated that miRNA27a rs895819 might play a protective role in diabetes, and miRNA146a rs2910164 likely had no association with diabetes. 31577754

2019

dbSNP: rs1060366
rs1060366
0.010 GeneticVariation BEFREE Thus, allele A of G94A SNP (rs1060366) could be a risk allele for diabetes susceptibility among Egyptian patients. 31523248

2019

dbSNP: rs149131600
rs149131600
T 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs17137004
rs17137004
A 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs4258701
rs4258701
T 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs59825600
rs59825600
A 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs6688849
rs6688849
A 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs6706313
rs6706313
A 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs74375025
rs74375025
A 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs780093
rs780093
T 0.700 GeneticVariation GWASCAT Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria. 31511532

2019

dbSNP: rs1333049
rs1333049
0.740 GeneticVariation BEFREE For CHD patients, rs1333049 decreased the risk of diabetes under heterozygote (p = .014) and dominant (p = .024) models. 31496134

2019

dbSNP: rs28938469
rs28938469
0.010 GeneticVariation BEFREE We explored the gene responsible for diabetes in two brothers, who were suspected to have diabetes </span>at 15 and 18 years-of-age, respectively, with whole exome sequencing, and identified a compound heterozygous ABCC8 gene mutation (p.Arg168Cys and p.Arg1421Cys). 31479591

2020

dbSNP: rs756823374
rs756823374
0.010 GeneticVariation BEFREE We explored the gene responsible for diabetes in two brothers, who were suspected to have diabetes at 15 and 18 years-of-age, respectively, with whole exome sequencing, and identified a compound heterozygous ABCC8 gene mutation (p.Arg168Cys and p.Arg1421Cys). 31479591

2020